======= BBC3 =======
== Gene Information ==
* **Official Symbol**: BBC3
* **Official Name**: BCL2 binding component 3
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=27113|27113]]
* **UniProt**: [[https://www.uniprot.org/uniprot/"Q96PG8|Q9BXH1"|"Q96PG8|Q9BXH1"]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=BBC3&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20BBC3|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/605854|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a member of the BCL-2 family of proteins. This family member belongs to the BH3-only pro-apoptotic subclass. The protein cooperates with direct activator proteins to induce mitochondrial outer membrane permeabilization and apoptosis. It can bind to anti-apoptotic Bcl-2 family members to induce mitochondrial dysfunction and caspase activation. Because of its pro-apoptotic role, this gene is a potential drug target for cancer therapy and for tissue injury. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2011].
* **UniProt Summary**: N/A
No Pfam Domain information is available for this gene.
|release of cytochrome c from mitochondria|
|regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway|
|positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway|
|positive regulation of release of cytochrome c from mitochondria|
|intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress|
|positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway|
|regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway|
|regulation of release of cytochrome c from mitochondria|
|execution phase of apoptosis|
|positive regulation of establishment of protein localization to mitochondrion|
|positive regulation of intrinsic apoptotic signaling pathway|
|apoptotic mitochondrial changes|
|regulation of mitochondrial membrane permeability|
|regulation of establishment of protein localization to mitochondrion|
|ATPase binding|
|regulation of membrane permeability|
|activation of cysteine-type endopeptidase activity involved in apoptotic process|
|positive regulation of mitochondrion organization|
|positive regulation of protein localization to membrane|
|mitochondrial membrane organization|
|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process|
|intrinsic apoptotic signaling pathway|
|positive regulation of cysteine-type endopeptidase activity|
|regulation of intrinsic apoptotic signaling pathway|
|positive regulation of endopeptidase activity|
|positive regulation of apoptotic signaling pathway|
|regulation of mitochondrion organization|
|regulation of protein localization to membrane|
|positive regulation of peptidase activity|
|mitochondrial transport|
|regulation of cysteine-type endopeptidase activity involved in apoptotic process|
|regulation of cysteine-type endopeptidase activity|
|lysosome|
|response to endoplasmic reticulum stress|
|apoptotic signaling pathway|
|positive regulation of cellular protein localization|
|positive regulation of proteolysis|
|regulation of apoptotic signaling pathway|
|regulation of endopeptidase activity|
|mitochondrion organization|
|regulation of peptidase activity|
|positive regulation of establishment of protein localization|
|regulation of cellular protein localization|
|positive regulation of organelle organization|
|positive regulation of apoptotic process|
|positive regulation of programmed cell death|
|positive regulation of cell death|
|regulation of proteolysis|
|regulation of establishment of protein localization|
|positive regulation of hydrolase activity|
|membrane organization|
|regulation of cellular localization|
|apoptotic process|
|positive regulation of transport|
|positive regulation of intracellular signal transduction|
|regulation of protein localization|
|programmed cell death|
|cell death|
|positive regulation of cellular component organization|
|mitochondrion|
|regulation of hydrolase activity|
|regulation of organelle organization|
|positive regulation of catalytic activity|
|regulation of apoptotic process|
|regulation of programmed cell death|
|positive regulation of cellular protein metabolic process|
|positive regulation of signal transduction|
|regulation of cell death|
|intracellular signal transduction|
|cellular response to stress|
|positive regulation of protein metabolic process|
|positive regulation of molecular function|
|positive regulation of cell communication|
|positive regulation of signaling|
|regulation of intracellular signal transduction|
|regulation of transport|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|1.71|
|[[:results:exp512|Olaparib 4μM R08 exp512]]|1.88|
|[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|2|
|[[:results:exp485|GSK626616 14μM R08 exp485]]|2.28|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 13215
* **Expression level (log2 read counts)**: 1.69
{{:chemogenomics:nalm6 dist.png?nolink |}}